Notable Analyst Rating Changes 9/2: TXT, CBE, SI, PAY, BBD Upgraded; ROK, GIS, HOLX, DHI, RYL, NVAX Downgraded
Up)
UPGRADES:
Goldman Sachs upgraded Textron (NYSE: TXT) from Neutral to Buy and added the stock to their Conviction Buy List. The firm set a $23 price target, representing 48% upside.
Citi upgrades Cooper Industries (NYSE: CBE) from Hold to Buy. Price target increased from $37 to $40.
UBS upgrades Siemens AG (NYSE: SI) from Sell to Neutral.
RBC Capital upgrades VeriFone (NYSE: PAY) from Underperform to Sector Perform. The firm also raised its price target on the stock from $8 to $13.
JPMorgan upgrades Banco Bradesco ADS (NYSE: BBD) all the way from Underweight to Overweight, also raising its price target from $13 to $21.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades Rockwell Automation (NYSE: ROK) from Hold to Sell, price target $32.
Soleil Securities downgrades General Mills (NYSE: GIS) from Buy to Hold. Price Target $62. Click here to see more color on the downgrade.
Canaccord Adams downgrades Hologic (Nasdaq: HOLX) from Buy to Hold.
An analyst at UBS has downgraded shares of two top homebuilders, D.R. Horton (NYSE: DHI) and Ryland (NYSE: RYL). The firm moved its investment rating on D.R. Horton from Neutral to Sell, maintaining a $10 price target, and its rating on Ryland from Buy to Neutral, maintaining a $24 target.
Oppenheimer downgrades Novavax (Nasdaq: NVAX) from Outperform to Perform. Price target lowered to $6.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
BofA/Merrill reinstated coverage on Gilead Sciences (Nasdaq: GILD) at Buy, Amgen (Nasdaq: AMGN) and Celgene (Nasdaq: CELG) at Neutral, and Biogen (Nasdaq: BIIB) at Underperform.
Credit Suisse initiates coverage on Rackspace (NYSE: RAX) with an Outperform rating. Price target $18.
Barrington Research initiates coverage on Rosetta Stone (NYSE: RST) with an Outperform rating. Price target $26.
Jefferies & Co initiates coverage on Fossil (Nasdaq: FOSL) with a Buy rating. Price target $32.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Goldman Sachs upgraded Textron (NYSE: TXT) from Neutral to Buy and added the stock to their Conviction Buy List. The firm set a $23 price target, representing 48% upside.
Citi upgrades Cooper Industries (NYSE: CBE) from Hold to Buy. Price target increased from $37 to $40.
UBS upgrades Siemens AG (NYSE: SI) from Sell to Neutral.
RBC Capital upgrades VeriFone (NYSE: PAY) from Underperform to Sector Perform. The firm also raised its price target on the stock from $8 to $13.
JPMorgan upgrades Banco Bradesco ADS (NYSE: BBD) all the way from Underweight to Overweight, also raising its price target from $13 to $21.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citi downgrades Rockwell Automation (NYSE: ROK) from Hold to Sell, price target $32.
Soleil Securities downgrades General Mills (NYSE: GIS) from Buy to Hold. Price Target $62. Click here to see more color on the downgrade.
Canaccord Adams downgrades Hologic (Nasdaq: HOLX) from Buy to Hold.
An analyst at UBS has downgraded shares of two top homebuilders, D.R. Horton (NYSE: DHI) and Ryland (NYSE: RYL). The firm moved its investment rating on D.R. Horton from Neutral to Sell, maintaining a $10 price target, and its rating on Ryland from Buy to Neutral, maintaining a $24 target.
Oppenheimer downgrades Novavax (Nasdaq: NVAX) from Outperform to Perform. Price target lowered to $6.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
BofA/Merrill reinstated coverage on Gilead Sciences (Nasdaq: GILD) at Buy, Amgen (Nasdaq: AMGN) and Celgene (Nasdaq: CELG) at Neutral, and Biogen (Nasdaq: BIIB) at Underperform.
Credit Suisse initiates coverage on Rackspace (NYSE: RAX) with an Outperform rating. Price target $18.
Barrington Research initiates coverage on Rosetta Stone (NYSE: RST) with an Outperform rating. Price target $26.
Jefferies & Co initiates coverage on Fossil (Nasdaq: FOSL) with a Buy rating. Price target $32.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Goldman Sachs Conviction Buy List, Credit Suisse, UBS, JPMorgan, Citi, Jefferies & Co, Canaccord Adams, Soleil Securities, Bank of America, RBC Capital, Notable Analyst Rating ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
